Skip to main content

Theophylline (International)

Note: In some countries, this medicine may only be approved for veterinary use.

In the US, Theophylline (theophylline systemic) is a member of the drug class methylxanthines and is used to treat Apnea of Prematurity, Asthma, Asthma - acute and Asthma - Maintenance.

US matches:

Scheme

BAN

ATC (Anatomical Therapeutic Chemical Classification)

R03DA04,R03DA54,R03DA74,R03DB04

CAS registry number (Chemical Abstracts Service)

0000058-55-9

Chemical Formula

C7-H8-N4-O2

Molecular Weight

180

Therapeutic Categories

Bronchodilator

Non-selective phosphodiesterase inhibitor

Diuretic agent

Cardiac stimulant

Treatment of heart failure (adjunct)

Xanthine derivative

Treatment of asthma and COPD

Chemical Names

1,3-Dimetyl-xantin

1H-Purine-2,6-dione, 3,7-dihydro-1,3-dimetyl-

Foreign Names

Generic Names

Brand Names

Glossary

TermDefinition
BANBritish Approved Name
BANMBritish Approved Name (Modified)
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.